Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2026-03-03 @ 2:20 PM
Study NCT ID:
NCT02166905
Status:
COMPLETED
Last Update Posted:
2023-02-24
First Post:
2014-04-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, and IDO1 Inhibitor INCB024360 in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-20
Completion Date Type:
ACTUAL
First Submit Date:
2014-04-21
First Submit QC Date:
None
Study First Post Date:
2014-06-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-03-22
Results First Submit QC Date:
None
Results First Post Date:
2023-02-24
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-27
Last Update Post Date:
2023-02-24
Last Update Post Date Type:
ACTUAL